Biotech · Private company
OSI Pharmaceuticals
Track this companyFree. Adds OSI Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials120 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- erlotinibPhase 2 · Recurrent or Refractory Pediatric EpendymomaClinicalTrials.gov · fetched Nov 12, 2026
- ErlotinibPhase 2 · EpendymomaClinicalTrials.gov · fetched Nov 12, 2026
- etoposidePhase 2 · Recurrent or Refractory Pediatric EpendymomaClinicalTrials.gov · fetched Nov 12, 2026
- erlotinibPhase 1 · Advanced Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- gemcitabinePhase 1 · Advanced Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- nab-paclitaxelPhase 1 · Advanced Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205PHASE2 · TERMINATED · started May 23, 2011ClinicalTrials.gov NCT01247922 · fetched Nov 12, 2026
- Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line TherapyPHASE2 · COMPLETED · started Apr 14, 2011ClinicalTrials.gov NCT01180959 · fetched Nov 12, 2026
- EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant GliomasPHASE1 · COMPLETED · started Jan 7, 2011ClinicalTrials.gov NCT01257594 · fetched Nov 12, 2026
- Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric EpendymomaPHASE2 · TERMINATED · started Sep 27, 2010ClinicalTrials.gov NCT01032070 · fetched Nov 12, 2026
- Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal CancerPHASE1 · COMPLETED · started Jul 1, 2010ClinicalTrials.gov NCT01154335 · fetched Nov 12, 2026
- Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid LeukemiaPHASE2 · COMPLETED · started Jul 1, 2010ClinicalTrials.gov NCT01174043 · fetched Nov 12, 2026
- Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic CancerPHASE1 · COMPLETED · started Feb 3, 2010ClinicalTrials.gov NCT01010945 · fetched Nov 12, 2026
- Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell CarcinomaPHASE2 · COMPLETED · started Jul 1, 2009ClinicalTrials.gov NCT00942734 · fetched Nov 12, 2026
- Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic CancerPHASE2 · TERMINATED · started Mar 1, 2008ClinicalTrials.gov NCT00640978 · fetched Nov 12, 2026
- Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung CancerPHASE2 · COMPLETED · started Jul 5, 2007ClinicalTrials.gov NCT00553800 · fetched Nov 12, 2026
- Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)PHASE2 · COMPLETED · started Mar 1, 2006ClinicalTrials.gov NCT00304278 · fetched Nov 12, 2026
- Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell CarcinomaPHASE1 · COMPLETED · started Nov 1, 2005ClinicalTrials.gov NCT01515137 · fetched Nov 12, 2026